Substrate
world

Bloomwell Expands Telehealth Cannabis Prescriptions in Germany

Bloomwell, a German telehealth company founded in 2020, connects patients with doctors for medical cannabis prescriptions that can be delivered to their homes. The company has grown to serve more than 100,000 patients through a network of 60 doctors. Germany’s legal cannabis market reached $944 million in sales last year, according to Forbes.

FO
1 source·May 15, 9:00 PM(13 days ago)·2m read
|
Bloomwell Expands Telehealth Cannabis Prescriptions in Germanythemarketherald.com.au
Audio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.

Bloomwell began operations in September 2020 in a two-room doctor’s practice in Frankfurt, Germany. At the time cannabis was still classified as a narcotic, requiring paper prescriptions, secure storage at pharmacies and physical delivery by couriers.

Post via X — linked by one of this story's sources.

The company’s first patient received cannabis within a week. The process has since been simplified. Patients use an app to submit medical history, complete a questionnaire and receive a prescription either immediately or after a video or in-person consultation at one of the company’s four locations.

Prescriptions are filled by pharmacies and products can be picked up or delivered within 24 to 48 hours via DHL.

Forbes estimates Bloomwell generates $55 million in annual revenue with a 30 percent margin. The company became profitable in 2024 and increased its number of prescriptions by 3,300 percent from 2024 to 2025. It expects to distribute between 25 and 30 tons of cannabis in 2026.

Bloomwell holds an estimated 15 to 20 percent share of the German market and continues to expand. Germany recorded $944 million in legal cannabis sales last year, up from $500 million in 2024, making it the largest such market in Europe. The company operates three main revenue streams.

It sells software and data tools to doctors for patient management, electronic prescriptions and treatment insights. It also sells software to pharmacists for inventory and order management. In addition it cross-sells vape devices, paraphernalia and travel documentation to patients.

Its wholesale arm, Ilios Santé, accounts for about 10 percent of revenue.

Bloomwell developed certified digital prescription software in cooperation with the German government. Cofounder Julian Wichmann said the shift from paper and overnight couriers to fully digital processes has allowed faster service. “We are a data powerhouse,” Wichmann stated.

Niklas Kouparanis, Bloomwell’s CEO, co-founded the company with Julian Wichmann, Samuel Menghistu and his sister Anna-Sophia Kouparanis. The siblings previously worked in cannabis wholesale. Niklas Kouparanis sold an earlier company, Farmako, to a Canadian firm for $15 million.

The company’s model resembles U.S. telehealth platforms. Patients choose cannabis products, see prices, pay and arrange delivery through the app. Kouparanis compared the experience to ordering on Amazon. Curaleaf acquired Emmac Life Sciences in 2021 for $286 million.

In February, Organigram acquired Berlin-based Sanity Group for $287 million.

Key Facts

100,000 patients
served by Bloomwell's doctor network
$55 million
estimated annual revenue
$944 million
Germany cannabis sales in 2025
3,300%
prescription growth 2024-2025
15-20%
Bloomwell German market share

Story Timeline

5 events
  1. September 2020

    Bloomwell conducted its first patient consultation in Frankfurt.

    1 source@Forbes
  2. 2024

    Bloomwell achieved profitability and prescriptions grew substantially.

    1 source@Forbes
  3. 2025

    Company prescriptions increased 3,300 percent from prior year.

    1 source@Forbes
  4. December 2025

    Bloomwell network distributed about two tons of cannabis.

    1 source@Forbes
  5. 2026

    Bloomwell expects to distribute 25 to 30 tons of cannabis.

    1 source@Forbes

Potential Impact

  1. 01

    Growth of telehealth cannabis access could expand patient numbers in Germany's $944 million market.

  2. 02

    Digital prescription software reduces administrative burden for doctors and pharmacies in Germany.

  3. 03

    Bloomwell's data tools may influence treatment decisions for pain, sleep and other conditions.

  4. 04

    Wholesale imports through Ilios Santé may increase cannabis supply from Australia, Denmark and Spain.

Transparency Panel

Sources cross-referenced1
Confidence score75%
Synthesized bySubstrate AI
Word count382 words
PublishedMay 15, 2026, 9:00 PM
Bias signals removed3 across 2 outlets
Signal Breakdown
Framing 1Editorializing 1Speculative 1

Related Stories

WHO Chief Visits DRC as Ebola Death Rate Reaches 30-50%The Guardian
world38 min ago

WHO Chief Visits DRC as Ebola Death Rate Reaches 30-50%

World Health Organization director-general Tedros Adhanom Ghebreyesus arrived in the Democratic Republic of the Congo to support containment of a new Ebola outbreak. The agency revised the death rate to 30-50% based on confirmed cases and recorded 10 confirmed and 223 suspected d…

SK
The Guardian
2 sources
Greek National Charged in UK With Aiding Iran-Linked Intelligence Servicewesternjournal.com
world38 min ago

Greek National Charged in UK With Aiding Iran-Linked Intelligence Service

A 46-year-old Greek man living in Germany was charged under the UK National Security Act with assisting an intelligence service believed to be Iran by targeting a journalist at Iran International.

Reuters
BBC News
2 sources
Supreme Court Revives Havana Docks Lawsuit Over Confiscated Cuban Propertyupi.com
world2 hrs ago

Supreme Court Revives Havana Docks Lawsuit Over Confiscated Cuban Property

The U.S. Supreme Court sent a Helms-Burton Act case back to lower courts for further argument. The suit seeks damages from cruise lines that used docks seized by Cuba in 1959.

FO
1 source